Cutaneous infiltration by T-cell CD56+ lymphoma-leukemia;Infiltración cutánea por linfoma-leucemia de células T CD56+

Actas Dermo-Sifiliograficas

Volumn 94, Issue 4, 2003, Pages 251-254

  Hernández, Almudena ^a,b   Ruiz Genao, Diana P ^a   Fraga, Javier ^a   García Díez, Amaro ^a   Fernández Herrera, Jesús ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Unidad de Dermatología   (Spain)

Author keywords

CD56+ lymphomas; Natural killer cells; Non Hodgkin's lymphomas

Indexed keywords

CD56 ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CANCER INFILTRATION; CASE REPORT; CLINICAL FEATURE; CYTOGENETICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; SKIN INFILTRATE; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 0038715803     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(03)76681-2     Document Type: Article

References (12)

1. Ohshima K, Suzumiya J, Kikuchi M. The World Health Organization clasification of malignant lymphoma: Incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka. Pathol International 2002;52:1-12.
2. Siu LLP, Chan JKC, Kwong YL. Natural killer cell malignancies: Clinicopathologic and molecular features. Histo Histopathol 2002;17:539-54.
3. Rakozy CK, Mohamed AN, Vo TD, Khatilo G, Long PM, Eilender D, et al. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically and clinically diverse. Am J Clin Pathol 2001;116: 168-76.
4. Kluin PM, Gaulard P, Jaffe ES, Meijer CJLM, Müller-Hermelink HK, Pileri S. Peripheral T/NK lymphoma: A report of the IXth Workshop of the European Association for Haematopathology. Histopathology 2001;38:250-70.
5. El Shabrawi-Caelen L, Cerroni L, Kerl H. The clinicopathologic spectrum of cytotoxic lymphomas of the skin. Sem Cut Med Surg 2000;19:118-23.
6. Kinney MC. The role of morphologic features, phenotype, genotype and anatomic site in defining extranodal T-cell and NK-cell neoplasms. Am J Clin Pathol 1999;111S:104-8.
7. Tien H, Su I, Liu M, Lee F, Chen Y, Chuang S. Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphoma. Br J Haematol 1997; 97:621-5.
8. Wong KF, Chan JKC, Kwong YL. Identification of del (6) (q21q25) as a recurring chromosomal abnormality of putative NK cell lymphoma/leukaemia. Br J Haematol 1997; 98:922-6.
9. Kato N, Yasukawa K, Onozuka T, Kikuta H. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. J Am Acad Dermatol 1999;40:850-6.
10. Chan JKC, Siu VC, Wong Kf, Ng ES, Tsang WY, Chan CH et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon agressive neoplasm. Blood 1997;89:4501-13.
11. Imamura N, Kusunoki Y, Kawa-Ha K, Yumura K, Hara J, Oda K, et al. Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Hematol 1990;75:49-59.
12. Ginarte M, Abalde MT, Peteiro C, Fraga M, Alonso N, Toribio J. Blastoid NK cell leukemia/lymphoma with cutaneous involvement. Dermatology 2000;201:268-71.